Results 11 to 20 of about 3,685,138 (295)
Next-Generation Systemic Acquired Resistance [PDF]
AbstractSystemic acquired resistance (SAR) is a plant immune response to pathogen attack. Recent evidence suggests that plant immunity involves regulation by chromatin remodeling and DNA methylation. We investigated whether SAR can be inherited epigenetically following disease pressure by Pseudomonas syringae pv tomato DC3000 (PstDC3000).
Luna, E. +4 more
core +10 more sources
Background Approximately 10% of non‐small cell lung cancers (NSCLCs) that harbor epidermal growth factor receptor (EGFR) gene mutations have in‐frame insertions in exon 20 of the EGFR gene.
Masaya Nishino +9 more
doaj +1 more source
Somatic alterations in the epidermal growth factor receptor gene (EGFR) result in aberrant activation of kinase signaling and occur in ∼15% of non-small cell lung cancers (NSCLC).
Tatiana Shaurova +3 more
doaj +1 more source
Antimicrobial Resistance: Is There a ‘Light’ at the End of the Tunnel?
In recent years, with the increases in microorganisms that express a multitude of antimicrobial resistance (AMR) mechanisms, the threat of antimicrobial resistance in the global population has reached critical levels.
Leon G. Leanse +3 more
doaj +1 more source
The Central Role of Salivary Metalloproteases in Host Acquired Resistance to Tick Feeding
During feeding on vertebrate hosts, ticks secrete saliva composed of a rich cocktail of bioactive molecules modulating host immune responses. Although most of the proteinaceous fraction of tick saliva is of little immunogenicity, repeated feeding of ...
Jan Perner +6 more
doaj +1 more source
HSP90 inhibition overcomes EGFR amplification‐induced resistance to third‐generation EGFR‐TKIs
Background Patients with non‐small cell lung cancer (NSCLC) harboring activating EGFR mutations are sensitive to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) but inevitably develop resistance to the inhibitors mostly through ...
Sho Watanabe +9 more
doaj +1 more source
Background The resistance mechanism of the third generation of epidermal growth factor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is complex. Epithelial mesenchymal transition (EMT) is a common mechanism of EGFR‐TKI acquired resistance.
Qiong Qin +6 more
doaj +1 more source
Systemic Acquired Resistance [PDF]
Upon infection with necrotizing pathogens many plants develop an enhanced resistance to further pathogen attack also in the uninoculated organs. This type of enhanced resistance is referred to as systemic acquired resistance (SAR). In the SAR state, plants are primed (sensitized) to more quickly and more effectively activate defense responses the ...
openaire +2 more sources
Acquired resistance mechanisms to immunotherapy [PDF]
Harnessing the immune system to act against malignant tumors has long been investigated. Recently, checkpoint blockade mechanisms were identified as possible targets to be used in the immunotherapy field.
Teresa, Amaral, Claus, Garbe
openaire +2 more sources
PRMT5 promotes chemotherapy‐induced neuroendocrine differentiation in NSCLC
Background In response to therapeutic treatments, cancer cells can exhibit a variety of resistance phenotypes including neuroendocrine differentiation (NED).
Qi Shen +3 more
doaj +1 more source

